期刊文献+

APRI评价胆道闭锁和胆汁淤积综合征肝脏纤维化程度的临床意义 被引量:16

The assessment and significance of liver fibrosis in children with biliary atresia
原文传递
导出
摘要 目的探讨肝功能检查和门冬氨酸氨基转移酶/血小板指数(aspartate aminotr-ans—ferase-to-platelet ratio index,APRI)与肝脏纤维化程度的关系,阐述其在BA肝纤维化评估中的临床价值。方法收集2006年2月至2011年8月间在我院治疗的胆道闭锁患儿38例和胆汁淤积综合征患儿25例为研究对象。临床观察指标包括肝功能检查,肝脏活检切片,血小板指数;肝硬化程度采用Metavir分类,APRI的诊断陛评估采用ROC曲线,应用SPSS16.O统计学软件进行统计分析。并对本组患儿进行随访,随访时间是3~69个月(平均随访时间:20.7个月)。结果胆道闭锁组患儿ALP、γ-GT、DBIL(564.14±257.75、153.36±97.47、7.55±2.57)较胆汁淤积综合征组患儿存在明显升高(P〈0.05);胆道闭锁肝硬化组患儿Age、ALT、AST、γ-GT(84.50±24.72、225.07±109.68、331.64±130.93、951.07±667.24)较非肝硬化组明显升高,两组差异具有统计学意义(P〈0.05);胆汁淤积综合征肝纤维化组患儿Age、ALT、AST(84.76±14.28、159.92±61.76、238.15±62.60)较非肝纤维化组(54.17±11.17、98.92±58.08、151.17±41.44)明显升高,两组差异具有统计学意义(P〈0.05)。患儿绘制APRI的ROC曲线,用于判定肝硬化程度,胆道闭锁组敏感性为79%,特异性为88%;胆汁淤积综合征组敏感性为91%,特异性为79%。胆道闭锁中肝硬化组病死率显著高于非肝硬化组,且自体肝生存情况低于非肝硬化组。结论肝功能检查可以作为胆道闭锁的初步判断指标,绘制APRI的ROC曲线对于评价胆道闭锁及胆汁淤积综合征患儿的肝脏纤维化情况均有较高准确性和可靠性,可用于预测预后和提早做好肝移植准备,因其简单、无创性可以在临床上广泛应用。 Objective To investigate the correlation between the degree of liver fibrosis and as- partate aminotransferase-to-platelet ratio index in the children with biliary atresia. Methods This study included 38 cases of BA patients and 25 cases of patients with inspissated bile syndrome between February 2006 and August 2011. Several laboratory tests including serum liver function and APRI were performed. Liver wedge biopsy specimens were obtained during the surgical procedure, and his-topathologic analyses were performed using the Metavir classification. Statistical analysis was done u singSPSS 16.0. Results The levels of ALP , γ-GT, DBIL(564.14±257.75,153.36±97.47.7.55±2. 57)in the biliary atresia group were significantly higher than that of the inspissated bile syndrome group (P〈0. 05). Furthermore, Age, the level of ALT, AST, γ-GT (84. 50 ± 24. 72,225. 07 ± 109. 68,331.64 ± 130. 93,951.07 ± 667.24)of the non-cirrhosis group were significantly higher than that of cirrhosis group (P〈0. 05). There were significant difference in age, the level of ALT, AST between non-fibrosis group(54. 17 ± 11.17.98. 92 ± 58. 08. 151.17 ± 41.44)and fibrosis group(84. 76 ± 14. 28,159. 92± 61.76,238. 15 ± 62.61)) based on APRI(P〈0. 05). Diagnostic accuracy for liver fi-brosis degree was assessed by receiver operator curve (ROC) analysis. The sensitivity and the specific-ity of biliar atresia group were 79o/oo and 88~//00, respectively. The sensitivity and the specificity of in-spissated bile syndrome group were 91% and 79%, respectively. Conclusions Liver function test may be used as a preliminary screening test for hiliary atresia. Rendering the ROC curves of APRI for eval-uating hepatic fibrosis of biliary atresia and inspissated bile syndrome both have high accuracy and reli- ability. This simple and non-invasive test can be widely used in clinical practice.
出处 《中华小儿外科杂志》 CSCD 北大核心 2012年第11期815-819,共5页 Chinese Journal of Pediatric Surgery
基金 天津市卫生局重点攻关项目(项目编号:11KG120)
关键词 胆道闭锁 胆汁淤积 肝纤维化 APRI Biliary atresia Cholestasis Liver fibrosis Aspartate aminotransferase-to-platelet ratio index
  • 相关文献

参考文献11

  • 1Mieli-Vergani G, Vergani D. Biliary atresia. Semin Immunopathol, 2009,31 (3) : 371-381.
  • 2Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology , 1996,24: 289-293.
  • 3曹玉宁,李森林.肝纤维化无创诊断的研究进展[J].临床肝胆病杂志,2011,27(2):214-217. 被引量:10
  • 4Lai MW, Chang Mn, Hsu SC. Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: A prospective study. J Pediatr Gastroenterol Nutr, 1994,18:121-127.
  • 5Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they' re hatched. Gut , 2006, 55 (3) :310-312.
  • 6Cadrand JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Assoeiation for the study of the liver (AFEF). Hepatology ,2000,32(3) :477-481.
  • 7Sang Y, Jae Y, Seok J, et al. Assessment of liver fihrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia. Hepatology and Nutrition, 2010, 51 (2) : 198-202.
  • 8蒋永芳,李耐萍.肝纤维化无创诊断的进展及展望[J].科技导报,2011,29(16):75-79. 被引量:5
  • 9Anna Alisi PhD, Research Scientist, Rita de Vito, et al. Liver fibrosis in paediatric liver disease. Gastroenterology ,2011,25: 259-268.
  • 10de Ledinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using Fibroscan= feasibility study and comparison with Fibrotest, aspartate transaminase to platelet ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007; 45 : 443-450.

二级参考文献68

  • 1沈赟玲,陆伦根,曾民德.肝纤维化血清学诊断研究进展[J].胃肠病学,2007,12(7):425-427. 被引量:8
  • 2Manning DS,Afdhal NH.Diagnosis and quantitation of fibrosis[J]. Gastroenterology,2008, 134(6):1670-1681.
  • 3Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C[J]. Hepatology,2003, 38(6): 1449-1457.
  • 4Gressner OA,Weiskirchen R,Gressner AM.Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre- disposition pending between fiction and reality[J]. J Cell Mot Med, 2007,11(5): 1031-1051.
  • 5Dufour DR. Assessment of liver fibrosis:can serum become the sample of choice?[J]. Clin Chem, 2005, 51(10):1763-1764.
  • 6Tarcin O, Gedik N, Karakoyun B, et al. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-ductligation in rats[J]. Dig Dis Sci, 2008, 53(7):1938-1945.
  • 7Kurien BT, Patel NC, Porter AC, et al. Prolidase deficiency and the biochemical assays used in its diagnosis[J]. Anal Biochem, 2006, 349(2): 165-175.
  • 8Kayadibi H, Gultepe M, Yasar B, et al. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease:A surrogate marker to distinguish steatohepatitis from simple steatosis[J]. Dig Dis Sci, 2009, 54(8):1764-1771.
  • 9Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury[J].J Biol Chem,2000, 275(4):2247-2250.
  • 10Zeremski M,Dimova R,Brown Q,et aI.Peripheral CXCR3- associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus Infection[J].J Infect Dis,2009, 200(11): 1774-1780.

共引文献13

同被引文献170

引证文献16

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部